98%
921
2 minutes
20
Objective: The 12-item Partners in Health scale (PIH) was developed in Australia to measure self-management behaviour and knowledge in patients with chronic diseases, and has undergone several changes. Our aim was to assess the construct validity and reliability of the latest PIH version in Dutch COPD patients.
Methods: The 12 items of the PIH, scored on a self-rated 9-point Likert scale, are used to calculate total and subscale scores (knowledge; coping; recognition and management of symptoms; and adherence to treatment). We used forward-backward translation of the latest version of the Australian PIH to define a Dutch PIH (PIH(Du)). Mokken Scale Analysis and common Factor Analysis were performed on data from a Dutch COPD sample to investigate the psychometric properties of the Dutch PIH; and to determine whether the four-subscale solution previously found for the original Australian PIH could be replicated for the Dutch PIH.
Results: Two subscales were found for the Dutch PIH data (n = 118); 1) knowledge and coping; 2) recognition and management of symptoms, adherence to treatment. The correlation between the two Dutch subscales was 0.43. The lower-bound of the reliability of the total scale equalled 0.84. Factor analysis indicated that the first two factors explained a larger percentage of common variance (39.4% and 19.9%) than could be expected when using random data (17.5% and 15.1%).
Conclusion: We recommend using two PIH subscale scores when assessing self-management in Dutch COPD patients. Our results did not support the four-subscale structure as previously reported for the original Australian PIH.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001637 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161595 | PLOS |
BMC Prim Care
September 2025
Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
Background: Pressurised metered-dose inhalers (pMDIs), often prescribed for the treatment of COPD and asthma have a high global warming potential (GWP) compared to dry powder inhalers (DPIs) and soft-mist inhalers. Despite calls to switch from high to DPIs or soft-mist inhalers, prescriptions of pMDIs have increased in recent years. Understanding healthcare providers' preferences can help develop strategies to promote prescribing low GWP inhalers.
View Article and Find Full Text PDFCells
July 2025
Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease predominantly of the small airways and parenchyma. COPD lungs exhibit an influx of circulating innate immune cells, which, when isolated, display impaired functions, including imbalanced protease secretion. In addition to immune cells, the extracellular matrix (ECM) plays a crucial role in COPD pathology.
View Article and Find Full Text PDFNed Tijdschr Geneeskd
August 2025
Universiteit Maastricht, afd. Huisartsgeneeskunde, Maastricht.
Chronic conditions represent an increasing public health challenge. While concepts like person-centered care, shared decision-making, and self-management are increasingly promoted, their practical realization remains difficult within our disease-centered healthcare system. The Assessment of Burden of Chronic Conditions (ABCC) tool may contribute to a more person-centered approach within the current healthcare system.
View Article and Find Full Text PDFSci Rep
July 2025
Department of Research and Development, Ciro, Horn, The Netherlands.
Physical activity (PA) is a well-established prognostic marker in Chronic Obstructive Pulmonary Disease (COPD). Traditional PA metrics, such as step count, often overlook movement intensity, while energy expenditure (EE) relies on indirect calorimetry assumptions. To address these limitations, we propose a data-driven PA metric that integrates movement frequency and amplitude derived from raw accelerometer data.
View Article and Find Full Text PDFLancet Respir Med
August 2025
Department of Family Medicine, Care and Public Health Research Institute, Maastricht 6200MD, Netherlands.